A clinical study to investigate long term safety of tobramycin inhalation powder (TIP) in patients with Cystic Fibrosis A clinical study to investigate long term safety of tobramycin inhalation powder (TIP) in patients w ...
A single arm, open-label, multicenter, Phase IV trial toassess long term safety of tobramycin inhalation powder(TIP) in patients with Cystic Fibrosis A single arm, open-label, multicenter, Phase IV trial toassess long term safety of tobramycin inhala ...
Pseudomonas aeruginosa infection in cystic fibrosis patients MedDRA version: 14.0;Level: LLT;Classification code 10021860;Term: Infection pseudomonas aeruginosa;System Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01] Pseudomonas aeruginosa infection in cystic fibrosis patients MedDRA version: 14.0;Level: LLT;Classif ...